FUNCTIONAL MEDICINE BLOG 

Includes over 800 monographs reporting on emerging studies in the medical and scientific literature of practical clinical importance, easily searched for content.

High protein beats high carbohydrate diet for biomarkers of metabolic syndrome

Regulating insulin is the key factor metabolic syndrome, diabetes and weight loss. In accordance with that, a randomized controlled trial just published in the journal Diabetes Care offers more evidence that a higher protein (with carbohydrate) diet improves multiple biomarkers better than a high carbohydrate diet.

Read More

More on the autoimmunity of osteoarthritis

A paper just published in the journal Clinical Immunology reminds clinicians that osteoarthritis occurs when there is a pathological immune response to articular cartilage. "Even though osteoarthritis (OA) is mainly considered as a degradative condition of the articular cartilage, there is increasing body of data demonstrating the involvement of all branches of the immune system."

Read More

Data shows high intake of omega-6 fatty acids is not advised for cardiovascular health

Research recently published in BMJ (British Medical Journal) examines accumulated data to reveal that advice given by the American Heart Association to increase consumption of omega-6 fatty acids, particularly linolenic acid found in corn, sunflower, safflower, and soybean oils, is misguided for cardiovascular health.

Read More

Prostate enlargement is promoted by autoimmune inflammation

Prostate enlargement—benign prostatic hyperplasia (BPH)—is fundamentally an inflammatory process that can undergo conversion to malignancy and emerge as prostate cancer. The authors of a study just published in The Journal of Urology offer important evidence that autoimmune phenomena drive prostate inflammation and enlargement.

Read More

Bisphosphonates adversely affect orthodontic treatment

Bisphosphonates are drugs used to increase bone density by killing off the cells that resorb old bone (osteoclasts) to 'make room' for new bone cells. Bisphosphonates include alendronate (Fosamax and Binosto), zoledronic acid (Reclast), risedronate (Actonel) and ibandronate (Boniva)...A study just published in the American Journal of Orthodontics & Dentofacial Orthopedics documents adverse effects of bisphosphonates on orthodontic outcomes.

Read More